Pimavanserin in Parkinson’s Disease-induced Psychosis: A Literature Review

Pimavanserin was approved for treating Parkinson’s disease (PD) psychosis, based upon 21 completed studies. This review article is to understand PD psychosis and assess the efficacy and safety of pimavanserin. A literature search was carried out using the keyword “pimavanserin” and cross-referencing...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Rikinkumar S, Bhela, Jatminderpal, Tahir, Muhammad, Pisati, Sindhu Reddy, Hossain, Sadaf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760879/
https://www.ncbi.nlm.nih.gov/pubmed/31572642
http://dx.doi.org/10.7759/cureus.5257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760879/
https://www.ncbi.nlm.nih.gov/pubmed/31572642
http://dx.doi.org/10.7759/cureus.5257

Ejemplares similares